9.42
0.00
(0.00%)
At close: January 9 at 7:00:00 PM EST
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in CHF | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | 10.3M | 4.6M | 24.41M | 47.73M |
Low Estimate | 10.3M | 4.6M | 24M | 35.47M |
High Estimate | 10.3M | 4.6M | 24.83M | 60M |
Year Ago Sales | -- | -- | 103.38M | 24.41M |
Sales Growth (year/est) | -- | -- | -76.38% | 95.51% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
SPHDF | -- | -- | -- | -- |
S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
2HA.MU Spero Therapeutics Inc
0.9680
-2.52%
FYB.F Formycon AG
62.50
+1.63%
ARTH Arch Therapeutics, Inc.
0.1701
-14.95%
FYB.DE Formycon AG
62.70
+1.46%
207940.KS Samsung Biologics Co.,Ltd.
1,000,000.00
-0.60%
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
ACOG Alpha Cognition Inc. Common Stock
6.10
+6.56%
22UA.DE BioNTech SE
119.40
+0.93%
ENTA Enanta Pharmaceuticals, Inc.
5.09
-1.36%
TVTX Travere Therapeutics, Inc.
18.09
-4.79%